Pregled bibliografske jedinice broj: 348194
Which patients with hypertrophic cardiomyopathy should receive a cardioverter defibrillator?
Which patients with hypertrophic cardiomyopathy should receive a cardioverter defibrillator? // Acta clinica Croatica, 44 (2005), 4; 389-394 (podatak o recenziji nije dostupan, članak, stručni)
CROSBI ID: 348194 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Which patients with hypertrophic cardiomyopathy should receive a cardioverter defibrillator?
Autori
Petrač, Dubravko
Izvornik
Acta clinica Croatica (0353-9466) 44
(2005), 4;
389-394
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
cardiomyopathy-therapy; defibrillators-implantable; risk factors
Sažetak
Ventricular tachyarrhythmias are the most common cause of sudden cardiac detah in hypertrophic cardiomyopathy. ICD is strongly warranted for secondary prevention of sudden death in patients who have survived cardiac arrest or spontanous sustained ventricular tachycardia. Because the presence of two or more risk factors confers an annual mortality rat of sudden death of 3%-&% or more, their presence in patients with hypertrophic cardiomyopathy justifes prophylactic therapy with ICD for primary prevention of sudden death.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
Uključenost u ostale bibliografske baze podataka::
- Excerpta Medica
